Bloomberg Intelligence

Skyler's Wahlgren on Anti-Aging Neuropeptide Skin Care (Audio)

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Paul Wahlgren, Managing Director of Skyler Brand Ventures, on luxury skin care and their patended neuropeptide technology used in a new concentrate for the face: XEP-30.

See omnystudio.com/listener for privacy information.

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file